# The Coalition for Epidemic Preparedness Innovations has committed around 818-million-rand to pharma company Moderna and to two other groups. This is to help accelerate the development of a vaccine against the Bundibugyo strain of the Ebola virus, which has swept through the Democratic Republic of Congo and Uganda. The outbreak has caused 250 deaths and over one-thousand suspected cases. CEPI CEO, Richard Hatchett, says with Bundibugyo spreading rapidly and no licensed vaccines, every day counts in the race against this deadly disease:
Global health organisation CEPI fast-tracking three promising Ebola vaccines under development [SOUND]
ENG HatchettOnBundibugyoVirus